Staphylococcal Skin Infections

Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees

Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA

Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

The Natural History of Community-Associated MRSA Infections and Decolonization Strategies

Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections

An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections

A Complicated Skin and Soft-tissue Infection Patient Registry

A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients

Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Staphylococcus Aureus Decolonization Study

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections